发明名称 |
Conformation-Stabilized TRAP Antigens |
摘要 |
This invention relates to compositions and methods for eliciting an immune response against a parasite of the genus Plasmodium in a mammal. |
申请公布号 |
US2015147349(A1) |
申请公布日期 |
2015.05.28 |
申请号 |
US201314379050 |
申请日期 |
2013.02.15 |
申请人 |
Children's Medical Center Corporation |
发明人 |
Springer Timothy A.;Lu Chafen;Song Gaojie;Koksal Adem |
分类号 |
C07K14/445;A61K39/015 |
主分类号 |
C07K14/445 |
代理机构 |
|
代理人 |
|
主权项 |
1. A Plasmodium falciparum Thrombospondin-Related Anonymous Protein (TRAP) antigen, wherein the antigen sequence comprises one or more of the following (numbering relative to SEQ ID NO:5):
(a) Mutation at Cysteine 55 to a non-cysteine amino acid; (b) Mutation of N-linked glycosylation sites; (c) Mutation of Ala-216/Asn-222 or Lys-224/Gln-78 to cysteine to create a TRAP that is stabilized in the open conformation; (d) Mutation of Asn-213/Ala-233, Ala-216/Phe-230, or Met-231/Gln-78 to cysteine to create a TRAP that is stabilized in the closed conformation; (e) Deletion of N-terminal and/or C-terminal residues to create a TRAP fragment that is stabilized in the closed conformation comprising V47-V238; (f) Deletion of N-terminal and/or C-terminal residues to create a TRAP fragment that is stabilized in the open conformation comprising V47-M231. |
地址 |
Boston MA US |